Lysine residues of Epstein–Barr virus-encoded nuclear antigen 2 do not confer secondary modifications via ubiquitin or SUMO-like proteins but modulate transcriptional activation

References

1. Bornkamm G. W., Hammerschmidt W. 2001; Molecular virology of Epstein–Barr virus. Philosophical Transactions of the Royal Society of London B Biological Sciences 356:437–459
   [Google Scholar]
2. Bradbury E. M. 1992; Reversible histone modifications and the chromosome cell cycle. Bioessays 14:9–16
   [Google Scholar]
3. Cohen J. I., Wang F., Kieff E. 1991; Epstein–Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. Journal of Virology 65:2545–2554
   [Google Scholar]
4. Fuentes-Panana E. M., Peng R., Brewer G., Tan J., Ling P. D. 2000; Regulation of the Epstein–Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway. Journal of Virology 74:8166–8175
   [Google Scholar]
5. Grässer F. A., Göttel S., Haiss P., Boldyreff B., Issinger O. G., Mueller-Lantzsch N. 1992; Phosphorylation of the Epstein–Barr virus nuclear antigen 2. Biochemical and Biophysical Research Communications 186:1694–1701
   [Google Scholar]
6. Grundhoff A. T., Kremmer E., Tureci O., Glieden A., Gindorf C., Atz J., Mueller-Lantzsch N., Schubach W. H., Grässer F. A. 1999; Characterization of DP103, a novel DEAD box protein that binds to the Epstein–Barr virus nuclear proteins EBNA2 and EBNA3C. Journal of Biological Chemistry 274:19136–19144
   [Google Scholar]
7. Hammerschmidt W., Sugden B. 1989; Genetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytes. Nature 340:393–397
   [Google Scholar]
8. Hochstrasser M. 2000; Biochemistry. All in the ubiquitin family. Science 289:563–564
   [Google Scholar]
9. Kempkes B., Spitkovsky D., Jansen-Dürr P., Ellwart J. W., Kremmer E., Delecluse H. J., Rottenberger C., Bornkamm G. W., Hammerschmidt W. 1995; B-cell proliferation and induction of early G1-regulating proteins by Epstein–Barr virus mutants conditional for EBNA2. EMBO Journal 14:88–96
   [Google Scholar]
10. Kremmer E., Kranz B., Hille A., Klein K., Eulitz M., Hoffmann-Fezer G., Feiden W., Herrmann K., Delecluse H.-J., Delsol G., Bornkamm G. W., Mueller-Lantzsch N., Grässer F. A. 1995; Rat monoclonal antibodies differentiating between the Epstein–Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B). Virology 208:336–342
    [Google Scholar]
11. Laux G., Adam B., Strobl L. J., Moreau-Gachelin F. 1994a; The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-Jκ interact with an Epstein–Barr virus nuclear antigen 2 responsive cis -element. EMBO Journal 13:5624–5632
    [Google Scholar]
12. Laux G., Dugrillon F., Eckert C., Adam B., Zimber-Strobl U., Bornkamm G. W. 1994b; Identification and characterization of an Epstein–Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes. Journal of Virology 68:6947–6958
    [Google Scholar]
13. Ling P. D., Hayward S. D. 1995; Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJκ. Journal of Virology 69:1944–1950
    [Google Scholar]
14. Ling P. D., Ryon J. J., Hayward S. D. 1993; EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein–Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. Journal of Virology 67:2990–3003
    [Google Scholar]
15. Ling P. D., Hsieh J. J., Ruf I. K., Rawlins D. R., Hayward S. D. 1994; EBNA-2 upregulation of Epstein–Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. Journal of Virology 68:5375–5383
    [Google Scholar]
16. Mahajan R., Delphin C., Guan T., Gerace L., Melchior F. 1997; A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88:97–107
    [Google Scholar]
17. Melchior F. 2000; SUMO – nonclassical ubiquitin. Annual Review of Cell and Developmental Biology 16:591–626
    [Google Scholar]
18. Rickinson A. B., Kieff E. 1996; Epstein–Barr Virus. In Fields Virology pp 2397–2446 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
    [Google Scholar]
19. Rickinson A. B., Young L. S., Rowe M. 1987; Influence of the Epstein–Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. Journal of Virology 61:1310–1317
    [Google Scholar]
20. Saitoh H., Hinchey J. 2000; Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. Journal of Biological Chemistry 275:6252–6258
    [Google Scholar]
21. Sjøblom A., Yang W., Palmqvist L., Jansson A., Rymo L. 1998; An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein–Barr virus LMP1 gene promoter. Journal of Virology 72:1365–1376
    [Google Scholar]
22. Strobl L. J., Hofelmayr H., Stein C., Marschall G., Brielmeier M., Laux G., Bornkamm G. W., Zimber-Strobl U. 1997; Both Epstein–Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-Jκ. Immunobiology 198:299–306
    [Google Scholar]
23. Tong X., Yalamanchili R., Harada S., Kieff E. 1994; The EBNA-2 arginine–glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains. Journal of Virology 68:6188–6197
    [Google Scholar]
24. Tong X., Wang F., Thut C. J., Kieff E. 1995; The Epstein–Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein. Journal of Virology 69:585–588
    [Google Scholar]
25. Voss M. D., Hille A., Barth S., Spurk A., Hennrich F., Holzer D., Mueller-Lantzsch N., Kremmer E., Grässer F. A. 2001; Functional cooperation of the Epstein–Barr virus nuclear antigen 2 and the survival motor neuron protein in transactivation of the viral LMP1 promoter. Journal of Virology 75:11781–11790
    [Google Scholar]
26. Zhao B., Sample C. E. 2000; Epstein–Barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein–Barr virus nuclear antigen 2 through sequences encompassing an spi-1/spi-B binding site. Journal of Virology 74:5151–5160
    [Google Scholar]
27. Zimber-Strobl U., Strobl L. J., Meitinger C., Hinrichs R., Sakai T., Furukawa T., Honjo T., Bornkamm G. W. 1994; Epstein–Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-Jκ, the homologue of Drosophila suppressor of hairless. EMBO Journal 13:4973–4982
    [Google Scholar]